RFK JR. It cancels 500 million US dollars in financing to develop vaccines and target us

The US Department of Health and Humanitarian Services will cancel contracts and withdraw funding for some vaccines that are developed to combat respiratory viruses such as Covid-19 and influenza.

Robert F. Kennedy Junior in a statement on Tuesday that 22 projects, totaling $ 500 million, to develop vaccines using the Mercy Rana technology.

Kennedy’s decision to end the projects is the latest in a series that has long witnessed the agenda of the vaccine criticism that has long exceeded scientific standards in the country’s Ministry of Health. Kennedy withdrew recommendations about Covid-19 shots, launched the painting that provides vaccine recommendations, and refused to provide strong support for the vaccine with the exacerbation of the measles outbreak.

The Minister of Health criticized the Al-Morsal Rana vaccines in a video clip of his social media accounts, and explained the decision to cancel the projects led by leading pharmaceutical companies in the country, including Pfizer and Moderna, which provides protection against viruses such as influenza, Covid-19 and H5N1.

Kennedy said in the video: “To replace the troubled Marna programs, we are priority to develop safer and broader vaccine strategies, such as full virus vaccines and new platforms that do not collapse when viruses turn.”

Infectious diseases experts say the technology of the Merseuled Rana used in vaccines is safe, and they refer to its development during the first Trump administration while slowing the Korona 2020 virus. They warned of future epidemics, difficult to stop without the help of the Mercy Rana.

“Dangerous decision”

“I don’t think I have seen a more dangerous decision in public health during the fifty years at work,” said Mike Ostohm, a Minnesota University expert in infectious diseases and friendly preparations.

He pointed out that technology offers possible advantages of rapid production, and it is decisive in the event of a new pandemic that requires a new vaccine.

Dr. Paul Ofit, a vaccine expert at the Children’s Hospital in Philadelphia, said that the shelves of flexible projects are short -sighted, while continuing concerns about the pandemic of bird influenza on the horizon.

“Certainly saved millions of lives,” Ofit said of the current Merna vaccines.

Scientists use more than more than infectious diseases, as researchers around the world explore its use of immunotherapy for cancer. In the White House earlier this year, the billionaire technology pioneer, Larry Ellison, praised his ability to treat cancer.

Traditionally, vaccines require increased pieces of viruses, often in chicken eggs or giant cells, then purify that substance. A flexible approach begins with an excerpt from the genetic code that carries instructions to make proteins. Scientists choose protein to target, injecting this scheme and body makes just enough to cause immune protection – the production of its vaccine dose.

In a statement on Tuesday, HHS said, “The other uses of a flexible technology within the department are not affected by this advertisement.”

In its statement, the Ministry of Health said, adding that it will start “investing in better solutions.” No details were provided about what these other technologies may be.